{"filing":{"accession_number":"0001193125-26-343474","cik":"0001227636","ticker":"STIM","company_name":"Neuronetics, Inc.","form":"8-K","filing_date":"2026-08-11","report_date":"2026-08-11","primary_document":"d78613d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1227636/000119312526343474/d78613d8k.htm"},"events":[{"id":26904,"run_id":24471,"accession_number":"0001193125-26-343474","anchor_item_number":"2.02","event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.97,"summary":"Neuronetics disclosed Q2 2026 financial results via press release, reporting total revenue of $41.6 million (up 9.1% year-over-year), improved gross margin to 51.1%, reduced net loss to $3.4 million from $10.1 million, and achievement of positive adjusted EBITDA of $0.3 million, along with updated full-year 2026 guidance.","company_name":"Neuronetics, Inc.","ticker":"STIM","filing_date":"2026-08-11","form":"8-K","submitted_at":null,"items":[{"id":28198,"accession_number":"0001193125-26-343474","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Item 2.02 discloses Neuronetics' financial results for Q2 2026 and six months ended June 30, 2026 via press release (Exhibit 99.1). The filing reports total revenue of $41.6 million (up 9.1% YoY), improved gross margin to 51.1%, reduced net loss to $3.4 million from $10.1 million, and achievement of positive adjusted EBITDA of $0.3 million. This is a standard quarterly earnings release with material financial metrics that would affect investor assessment of the company's operational performance and path to profitability.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-11T12:06:43.942620+00:00","company_name":"","ticker":null,"filing_date":""},{"id":28199,"accession_number":"0001193125-26-343474","item_number":"7.01","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Item 7.01 disclosure incorporates by reference Exhibit 99.2 (a presentation) and Exhibit 99.1, which is a comprehensive earnings release announcing Neuronetics' second quarter 2026 financial and operating results. The release includes detailed revenue figures ($41.6M, up 9.1% YoY), segment performance (Greenbrook up 16.8%), adjusted EBITDA improvement to $0.3M from a loss of $5.6M, and updated full-year 2026 guidance. This is a material quarterly earnings disclosure typical of Item 2.02 content furnished under Item 7.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-11T12:06:43.942620+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":28198,"accession_number":"0001193125-26-343474","item_number":"2.02","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.98,"reasoning":"Item 2.02 discloses Neuronetics' financial results for Q2 2026 and six months ended June 30, 2026 via press release (Exhibit 99.1). The filing reports total revenue of $41.6 million (up 9.1% YoY), improved gross margin to 51.1%, reduced net loss to $3.4 million from $10.1 million, and achievement of positive adjusted EBITDA of $0.3 million. This is a standard quarterly earnings release with material financial metrics that would affect investor assessment of the company's operational performance and path to profitability.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-11T12:06:43.942620+00:00","company_name":"Neuronetics, Inc.","ticker":"STIM","filing_date":"2026-08-11"},{"id":28199,"accession_number":"0001193125-26-343474","item_number":"7.01","item_title":null,"event_type":"earnings_release","event_domain":"financial","is_material":true,"confidence":0.95,"reasoning":"The Item 7.01 disclosure incorporates by reference Exhibit 99.2 (a presentation) and Exhibit 99.1, which is a comprehensive earnings release announcing Neuronetics' second quarter 2026 financial and operating results. The release includes detailed revenue figures ($41.6M, up 9.1% YoY), segment performance (Greenbrook up 16.8%), adjusted EBITDA improvement to $0.3M from a loss of $5.6M, and updated full-year 2026 guidance. This is a material quarterly earnings disclosure typical of Item 2.02 content furnished under Item 7.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-08-11T12:06:43.942620+00:00","company_name":"Neuronetics, Inc.","ticker":"STIM","filing_date":"2026-08-11"}]}